Viewing Study NCT01105468


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2025-12-29 @ 3:00 AM
Study NCT ID: NCT01105468
Status: TERMINATED
Last Update Posted: 2013-01-14
First Post: 2010-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Breath Gas Analysis for the Diagnosis of Breast Cancer
Sponsor: Ionimed Analytik GmbH
Organization:

Study Overview

Official Title: Leistungsbewertungsprüfung: Atemluftanalyse für Die Diagnose Von Brustkrebs, für Die Überwachung Der Therapie Und für Die Voraussage Des Metastasenrisikos
Status: TERMINATED
Status Verified Date: 2013-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Sponsor quit partnership in Oncotyrol-Center for Personalized Medicine, and consequential loss of public funding.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The volatile content of the exhaled breath gas of mamma carcinoma patients will be chemically analyzed by proton-transfer-reaction time of flight mass spectrometry.

The goal of the study is to determine typical breath gas components that allow to distinguish patients with mamma carcinoma from women without carcinoma. Further, the investigators will test whether these breath gas markers can be used as tumor markers, which change in a typical manner during the progress of the disease. Finally the data will be investigated for the presence of marker components, that identify patients who will develop metastasis.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: